Corrigendum to "Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies": [Immuno-Oncology and Technology 10 (2023) 100394]

{{output}}

[This corrects the article DOI: 10.1016/j.iotech.2023.100394.]. © 2023 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.

请注册登录后继续浏览